Human Frontier Science Program

Last updated
The Human Frontier Science Program
AbbreviationHFSP
Location
Key people
Shikekazug Nagata, HFSPO President, Warwick Anderson, HFSPO Secretary General

The International Human Frontier Science Program Organization (HFSPO) is a non-profit organization, based in Strasbourg, France, that funds basic research in life sciences. The organization implements the Human Frontier Science Program (HFSP) and is supported by 14 countries and the European Commission. Shigekazu Nagata is the HFSPO President and Chair of the Board of Trustees since 2018.

Contents

History

In 1986, Japanese scientists, supported by the Japanese Prime Minister's Council for Science and Technology, conducted a feasibility study to explore international collaboration in basic research. Subsequent discussions involving scientists from G7 summit nations and the European Union led to the "London Wise Men's Conference" in April 1987, endorsing the idea. Prime Minister Yasuhiro Nakasone proposed the Human Frontier Science Program at the Venice Economic Summit in June 10th 1987, gaining support from the Economic Summit partners and the Chairman of the European Community. The International Human Frontier Science Program Organization (HFSPO) was then established in 1989, with its secretariat in Strasbourg, France. Since 1990, the program has granted over 7000 awards to researchers from 70+ countries with 28 HFSP awardees later receiving the Nobel Prize for their scientific contributions.

Funding

.mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{}
contributing member states
European Union contribution Human Frontier Science Program.png
  contributing member states
  European Union contribution

HFSPO secures financial backing from a range of governments and research councils, including Australia, Canada, France, Germany, India, Israel, Italy, Japan, Republic of Korea, New Zealand, Singapore, Switzerland, the UK, USA, and the European Commission, representing non-G7 EU members. These contributions are consolidated into a unified budget, which is used to fund research fellowships and grants through HFSPO's peer review system, with a primary emphasis on science.

Funding programs

The organization offers Research grants, which encourage collaboration among scientists globally. These grants come in two types: Research Grants - Early Career and Research Grants - Program.

Postdoctoral Fellowships cater to individuals seeking experience in foreign labs, especially those early in their careers exploring different research fields. Fellows can also use these opportunities to establish independent research labs in their home countries.

Cross-Disciplinary Fellowships are designed for postdocs with Ph.D. degrees in the physical sciences, chemistry, mathematics, engineering and computer sciences who aim to gain training in biology.

HFSP funding primarily supports postdoctoral initiatives, with no provisions for undergraduate or PhD students.

HFSP peer review

International peer review is a fundamental part of the awarding process, involving two committees—one for Fellowships and one for Research Grants, each composed of 24 to 26 scientists. These committees have a diverse global representation of scientific experts, reviewing applications across all HFSP-supported scientific fields. The evaluation procedures undergo regular review, and the HFSP secretariat collaborates closely with committee members and the Council of Scientists.

HFSP Nakasone Award

In 2010, HFSP established the HFSP Nakasone Award to honour former Prime Minister Yasuhiro Nakasone of Japan for his vision in launching HFSP as a program of support for international collaboration and to foster early career scientists in a global context. The HFSP Nakasone Award is designed to recognise scientists who have undertaken frontier-moving research, including technological breakthroughs, which has advanced biological research. Both senior and junior scientists are eligible and peer-recognised excellence is the major criterion. The award can be made to an individual or a team of scientists. Award winners receive an unrestricted research grant of USD 10,000, a medal and personalised certificate. The award ceremony is held at the annual HFSP Awardees Meeting where the award winners are expected to deliver the HFSP Nakasone Lecture.

Recipients of the Award:

HFSP Journal

Launched in October 2006, the HFSP Journal aims to foster communication between scientists publishing innovative research at the frontiers of the life sciences. Peer review is designed to allow for the unique requirements of such papers and is overseen by an Editorial Board with members from different disciplines. The HFSP Journal offers its authors the option to pay a fee to make their research articles Open Access immediately upon publication. For other articles, access is limited to subscribers for the first 6 months after publication, but access is free thereafter.

The HFSP Journal ceased publication in July 2010 and was bought by the scientific publisher Taylor & Frances, to be re-launched in 2011.

In 2015 the HFSP reported that the former journal name had been hijacked in an apparent attempt to defraud researchers into publishing an apparent scam journal.

Related Research Articles

<span class="mw-page-title-main">Martin Nowak</span> Austrian-born scientist

Martin Andreas Nowak is an Austrian-born professor of mathematics and biology at Harvard University. He is one of the leading researchers in evolutionary dynamics. Nowak has made contributions to the fields of evolutionary theory, cooperation, viral dynamics, and cancer dynamics.

<span class="mw-page-title-main">Leukemia inhibitory factor</span> Mammalian protein found in Homo sapiens

Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate.

Wen-Hsiung Li is a Taiwanese-American scientist working in the fields of molecular evolution, population genetics, and genomics. He is currently the James Watson Professor of Ecology and Evolution at the University of Chicago and a Principal Investigator at the Institute of Information Science and Genomics Research Center, Academia Sinica, Taiwan.

<span class="mw-page-title-main">Tomas Lindahl</span> Swedish-British scientist

Tomas Robert Lindahl FRS FMedSci is a Swedish-British scientist specialising in cancer research. In 2015, he was awarded the Nobel Prize in Chemistry jointly with American chemist Paul L. Modrich and Turkish chemist Aziz Sancar for mechanistic studies of DNA repair.

<span class="mw-page-title-main">Angelika Amon</span> Austrian American academic molecular and cell biologist (1967–2020)

Angelika Amon was an Austrian American molecular and cell biologist, and the Kathleen and Curtis Marble Professor in Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Amon's research centered on how chromosomes are regulated, duplicated, and partitioned in the cell cycle. Amon was elected to the American Academy of Arts and Sciences in 2017.

Michael B. Elowitz is a biologist and professor of Biology, Bioengineering, and Applied Physics at the California Institute of Technology, and investigator at the Howard Hughes Medical Institute. In 2007 he was the recipient of the Genius grant, better known as the MacArthur Fellows Program for the design of a synthetic gene regulatory network, the Repressilator, which helped initiate the field of synthetic biology. He was the first to show how inherently random effects, or 'noise', in gene expression could be detected and quantified in living cells, leading to a growing recognition of the many roles that noise plays in living cells. His work in Synthetic Biology and Noise represent two foundations of the field of Systems Biology. Since then, his laboratory has contributed to the development of synthetic biological circuits that perform a range of functions inside cells, and revealed biological circuit design principles underlying epigenetic memory, cell fate control, cell-cell communication, and multicellular behaviors.

<span class="mw-page-title-main">Anthony A. Hyman</span> British biologist

Anthony Arie Hyman is a British scientist and director at the Max Planck Institute of Molecular Cell Biology and Genetics.

<span class="mw-page-title-main">David Julius</span> American physiologist and Nobel laureate 2021

David Jay Julius is an American physiologist and Nobel Prize laureate known for his work on molecular mechanisms of pain sensation and heat, including the characterization of the TRPV1 and TRPM8 receptors that detect capsaicin, menthol, and temperature. He is a professor at the University of California, San Francisco.

<span class="mw-page-title-main">Uri Alon</span> Israeli biologist and academic

Uri Alon is a Professor and Systems Biologist at the Weizmann Institute of Science. His highly cited research investigates gene expression, network motifs and the design principles of biological networks in Escherichia coli and other organisms using both computational biology and traditional experimental wet laboratory techniques.

<span class="mw-page-title-main">Aviv Regev</span> Bioinformatician

Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.

Gerard Ian Evan FRS, FMedSci is a British biologist and, since May 2022, Professor of Cancer Biology at King's College London and a principal group leader in the Francis Crick Institute. Prior to this he was Sir William Dunn Professor and Head of Biochemistry at the University of Cambridge (2009-2022).

<span class="mw-page-title-main">Jared Diamond bibliography</span> Author bibliography

Jared Diamond is an American scientist and author. Trained in physiology, and having published on ecology, anthropology, and linguistics, Diamond's work is known for drawing from a variety of fields. He is currently professor of geography at the University of California, Los Angeles (UCLA). Among his awards are a Pulitzer Prize and an International Cosmos Prize. Diamond splits his time between teaching at UCLA, researching birds of the Pacific islands, writing books about human societies, and promoting sustainable ecological practices. He formerly had a secondary career path in physiology and biophysics.

<span class="mw-page-title-main">Eva Neer</span> American biochemist

Eva Julia Neer (1937–2000) was an American physician, biochemist, and cell-biology scientist who gained U.S. national research awards for her discoveries on G-protein subunit structure and function. She described the physiological roles of these subunits as an integrated and versatile molecular system of signal transduction for membrane-receptor regulation of cell function. Her research concepts turned her into a world leader in G-protein studies and impinged widely on the general understanding of cell behavior.

<span class="mw-page-title-main">Peter Colman</span>

Peter Malcolm Colman is the head of the structural biology division at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia.

Cédric Blanpain is a Belgian researcher in the field of stem cells. He is a tenured professor of developmental biology and genetics at Université Libre de Bruxelles and director of the stem cell and cancer lab at its Faculty of Medicine. He was one of the first researchers in the world to use cell lineage tracing in cancer research and he showed for the first time the existence of cancer stem cells in solid tumors in vivo. He was selected by Nature as one of 10 People who mattered most in 2012 and he received the outstanding young investigator award of the International Society for Stem Cell Research.

Jacques Benveniste was a French immunologist born in Paris. In 1979, he published a well-known paper on the structure of platelet-activating factor and its relationship with histamine. He was head of allergy and inflammation immunology at the French biomedical research agency INSERM.

<span class="mw-page-title-main">Pavan Ramdya</span> US-American neuroscientist

Pavan Ramdya is an American and Swiss neuroscientist and bioengineer. His research centers on understanding the cognitive and neuromechanical control of behavior toward applications in robotics and artificial intelligence. He holds the Firmenich Next Generation Chair in neuroscience and bioengineering at EPFL, and is head of the Neuroengineering Laboratory at EPFL's School of Life Sciences.

Ludger Johannes is a French-German biochemist who has specialized in the field of endocytosis and intracellular trafficking. He and his team study how sugars attached to proteins or lipids influence the transport of biological material into eukaryotic cells.

<span class="mw-page-title-main">Alex Sigal</span> Virologist, biologist

Alex Sigal is a South Africa–based virologist at the Africa Health Research Institute (AHRI) in Durban, South Africa, Max Planck Institute for Infection Biology in Berlin, and University of KwaZulu-Natal in Durban. His work concentrates on evolution and persistence of the SARS-CoV-2 virus. His laboratory was the first to isolate the live B.1.351 (Beta) variant of SARS-CoV-2 first detected in South Africa. Sigal’s laboratory was also the first to report results on the ability of the Omicron variant to escape antibody neutralization in individuals who had two doses of the Pfizer BNT162b2 vaccine as well as from previous infections, with results also suggesting that vaccination combined with a booster or previous infection can offer protection from symptomatic infection with Omicron.

Clifford P. Brangwynne is a professor of chemical and biological engineering at Princeton University, the director of the Princeton Bioengineering Initiative, and the June K. Wu ’92 Professor in Engineering. He is also a researcher at the Howard Hughes Medical Institute.

References

    As of this edit, this article uses content from "Human Frontier Science Program" , which is licensed in a way that permits reuse under the Creative Commons Attribution-ShareAlike 3.0 Unported License, but not under the GFDL. All relevant terms must be followed.

    Further reading